Ignite Creation Date:
2024-05-05 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00441701
Status:
TERMINATED
Last Update Posted:
2019-01-02
First Post:
2007-02-28
Brief Title:
Study to Evaluate the Safety and Dose-Range of Navarixin SCH 527123 MK-7123 in Participants With Moderate to Severe Chronic Obstructive Pulmonary Disease COPD MK-7123-012
Sponsor:
Organization:
Merck Sharp Dohme LLC